TYRA Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

KUPNO 111670 min ago

@ $19.02

Wydano: 12 vas. 2024 @ 19:36

Zwrot: -13.51%

Poprzedni sygnał: vas. 12 - 16:39

Poprzedni sygnał: Sprzedaż

Zwrot: -0.94 %

Live Chart Being Loaded With Signals

Commentary (29 bal. 2024 @ 23:00):

Tyra Biosciences, Inc., a preclinical-stage biopharmaceutical company, focuses on developing therapies to overcome tumor resistance and enhance outcomes for patients with cancer...

Stats
Dzisiejszy wolumen	115 945
Średni wolumen	146 504
Kapitalizacja rynkowa	864.02M
EPS	$0 ( 2024-03-27 )
Następna data zysków	( $-0.460 ) 2024-05-02
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-10.15
ATR14	$0.0240 (0.15%)

Insider Trading

Date	Person	Action	Amount	type
2024-03-15	Fuhrman Alan	Buy	932	Common Stock
2024-03-15	Tada Hiroomi	Buy	1 968	Common Stock
2024-03-15	Harris Todd	Buy	1 880	Common Stock
2024-03-11	Bensen Daniel	Sell	200	Common Stock
2024-03-06	Bensen Daniel	Sell	1 733	Common Stock

INSIDER POWER
85.25
Last 100 transactions
Buy: 6 273 982 \| Sell: 603 690

Wolumen Korelacja

Długi: 0.05 (neutral)

Krótki: 0.47 (neutral)

Signal:(50.964) Neutral

Tyra Biosciences, Inc. Korelacja

10 Najbardziej pozytywne korelacje
DRNA	0.954
SUMO	0.939
IOAC	0.936
OCSL	0.935
IRMD	0.932
CMPI	0.922
XM	0.921
ALBO	0.92
SLMBP	0.919
PRAA	0.915

10 Najbardziej negatywne korelacje
GMII	-0.933
WASH	-0.921
AFYA	-0.913
EAR	-0.897
TRMK	-0.897
XPDI	-0.894
GOOD	-0.893
ALXO	-0.888
TUEM	-0.888
AVIR	-0.884

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Tyra Biosciences, Inc. Korelacja - Waluta/Towar

0.01
( neutral )

-0.33
( neutral )

0.00
( neutral )

0.15
( neutral )

0.53
( weak )

-0.14
( neutral )

Tyra Biosciences, Inc. Finanse

Annual	2023
Przychody:	$0
Zysk brutto:	$-353 000 (0.00 %)
EPS:	$-1.620

FY	2023
Przychody:	$0
Zysk brutto:	$-353 000 (0.00 %)
EPS:	$-1.620

FY	2022
Przychody:	$0
Zysk brutto:	$-296 000 (0.00 %)
EPS:	$-1.230

FY	2021
Przychody:	$0.00
Zysk brutto:	$0.00 (0.00 %)
EPS:	$-1.910

Financial Reports:

No articles found.

Tyra Biosciences, Inc.

Tyra Biosciences, Inc., a preclinical-stage biopharmaceutical company, focuses on developing therapies to overcome tumor resistance and enhance outcomes for patients with cancer. Its lead product candidate is TYRA-300, a selective inhibitor of fibroblast growth factor receptor (FGFR)3 for the treatment of muscle invasive bladder cancer. The company is also developing programs targeting FGFR2- intrahepatic cholangiocarcinoma,FGFR3-related achondroplasia, REarranged during transfection kinase, and FGFR4-related cancers. In addition, the company offers SNAP platform which enable rapid structural design through iterative molecular SNAPshots. Tyra Biosciences, Inc. was incorporated in 2018 and is based in Carlsbad, California.

Aktualne aktualizacje dla Tyra Biosciences, Inc. [TYRA]

Upcoming Earnings Alert